Cancer Control and Population Sciences In the News
The End-of-Life Nursing Education Consortium (ELNEC) curricula developed by City of Hope nurses is now available and has been shared in its 100th country, Bulgaria.
Where in the early days of the HIV epidemic the idea of stem cell transplants for HIV patients with cancer was considered crazy, the procedure is now commonly performed.
City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.
City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research (AACR) annual meeting from March 29 through April 3 in Atlanta.
City of Hope scientist, Rick Kittles, Ph.D., and his colleagues found that some commercial cell lines used for countless laboratory studies have mislabeled ancestry when it comes to minorities.
As the biomedical field races to develop therapies based on an individual’s genetic makeup, a City of Hope scientist and his colleagues found that some commercial cell lines used for countless laboratory studies have mislabeled ancestry when it comes to minorities.
If you've thought about trying one of those home DNA kits, think before you spit. Even the most elaborate home test only scratches the surface.
Dealing with air pollution is a fact of life in many California cities. Learn how it impacts your health and what you can do about it.
The overall cancer death rate has dropped by 27 percent over the last 25 years, according to data released last week by the American Cancer Society. City of Hope's James Lacey, Ph.D., M.P.H., breaks down the results.
William Dale, M.D., Ph.D., has been named the Arthur M. Coppola Family Chair in Supportive Care Medicine in recognition of his 20 years of work helping patients and their families make informed medical decisions that improve quality of life.
At 14, City of Hope patient Nicole Schulz was a girl on the go, and even acute myeloid leukemia couldn’t stop her. Now she's facing a new challenge - the side effects of her lifesaving treatment.
When Little League pitcher Jaylon Fong was 8, he was stricken with leukemia. At 12, he was finally declared cancer-free, only to relapse months later. But for him, cancer's just another opponent to beat.
The Journal of the American Medical Association Oncology invited City of Hope’s Victoria Seewaldt, M.D., to provide her expert commentary on two studies published today about ovarian and hepatocellular cancer prevention.
Patients with metastatic kidney cancer who have high rates of distress tend to have poorer overall survival compared to those with low distress, according to a new study by City of Hope researchers.
The Dr. Norman and Melinda Payson Professorships recognize City of Hope clinicians and researchers who have contributed greatly to biomedical research.
A new electronic monitor called Vivio, developed by Caltech with City of Hope, promises to make cardiac screening easier and more accessible for cancer patients and physicians.
City of Hope physicians Arti Hurria, M.D., a geriatric oncologist, and William Dale, M.D., Ph.D., a geriatrician and palliative care physician, co-chaired the panel that developed the new ASCO guidelines designed to help doctors assess and manage care for older adults.
City of Hope has received a five-year award totaling $2 million from the National Institute of Aging to establish a national research infrastructure that will facilitate and support significant innovative projects across the country addressing aging and cancer.
Joseph Alvarnas, M.D. describes himself as a storyteller, and for the City of Hope hematologist/oncologist, stories play a key role in how he sees the medical profession, his role in it, and even why he became a physician in the first place.
City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will highlight a variety of basic research and population studies at the annual meeting of the American Association for Cancer Research (AACR) in Chicago’s McCormick Place April 14 to 18.